For example, hotspot R298P mutations occurring in the methylation enzyme METTL14 may be involved in the proliferation of endometrial cancer cells by affecting the activity of AKT pathways, such as the AKT regulators PHLPP2 and mTORC2 [126]. This evidence concerns the gene AKT1 and endometrial cancer.